Nimesulide 100 mg + Phenylephrine HCl 10 mg + Unspecified Dihydrochloride 5 mg + Caffeine 30 mg Tablet

Nimesulide 100 mg + Phenylephrine HCl 10 mg + Unspecified Dihydrochloride 5 mg + Caffeine 30 mg Tablet is a tablet formulated with Nimesulide 100 mg + Phenylephrine HCl 10 mg + unspecified dihydrochloride 5 mg + Caffeine 30 mg. The active ingredient profile is Nimesulide; Phenylephrine HCl; Unspecified Dihydrochloride ingredient; Caffeine, placing the product in the multi-ingredient analgesic / decongestant combination category. This is a multi-ingredient symptom-management formulation with pharmacologically different components, so the exact approved indication must be taken from the manufacturer’s product literature. The source identifies this item as a tablet product but does not specify a coating or release characteristic on that line. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.